Construction of postoperative survival nomogram in patients with stage ⅢC1 cervical cancer and analysis of its clinical application value

CHEN Xiu-jie, HE Yu, HU Xiao-wen, WU Pan-pan, ZHU Man-man

Chinese Journal of Practical Gynecology and Obstetrics ›› 2025, Vol. 41 ›› Issue (7) : 742-746.

PDF(1378 KB)
PDF(1378 KB)
Chinese Journal of Practical Gynecology and Obstetrics ›› 2025, Vol. 41 ›› Issue (7) : 742-746. DOI: 10.19538/j.fk2025070116

Construction of postoperative survival nomogram in patients with stage ⅢC1 cervical cancer and analysis of its clinical application value

Author information +
History +

Abstract

Objective To analyze factors affecting the prognosis of patients with stage ⅢC1 cervical cancer and to develop a nomogram for exploring its value in prognosis evaluation. Methods A total of 91 patients with pathological diagnosis of stage ⅢC1 cervical cancer were included as research subjects, who underwent radical hysterectomy at the First Affiliated Hospital of Bengbu Medical University between January 2016 and December 2020. Prognostic factors were identified using Cox proportional hazards regression analysis, and a nomogram was constructed. The nomogram was evaluated using calibration curves, receiver operating characteristic (ROC) curves, and decision curve analysis (DCA). Results Tumor diameter ≥4cm, paracervical involvement, and lymph node ratio (LNR) ≥0.22 were the risk factors for 3-year OS of the patients with stage ⅢC1 cervical cancer. Tumor diameter ≥4cm, lymphovascular space invasion (LVSI), and LNR ≥0.22 were the risk factors for 3-year DFS of the patients with stage ⅢC1 cervical cancer. The calibration curves of nomogram demonstrated high prediction accuracy of this model, the ROC curves showed high predictive accuracy of the model, and DCA curve confirmed the clinical utility of the model. Conclusions Tumor size, LNR, paracervical involvement, and LVSI are risk factors affecting the prognosis of the patients with stage ⅢC1 cervical cancer. The constructed nomogram may help to guide doctors in stratification management and to take comprehensive treatment in order to improve patient outcomes.

Key words

stage ⅢC1 cervical cancer / prediction model / nomogram / prognosis

Cite this article

Download Citations
CHEN Xiu-jie , HE Yu , HU Xiao-wen , et al . Construction of postoperative survival nomogram in patients with stage ⅢC1 cervical cancer and analysis of its clinical application value[J]. Chinese Journal of Practical Gynecology and Obstetrics. 2025, 41(7): 742-746 https://doi.org/10.19538/j.fk2025070116

References

[1]
姚一菲, 孙可欣, 郑荣寿. 《2022全球癌症统计报告》解读:中国与全球对比[J]. 中国普外基础与临床杂志, 2024, 31(7):769-780. DOI:10.7507/1007-9424.202406046.
[2]
中国抗癌协会肿瘤内分泌专业委员会. 子宫颈癌手术分期中国专家共识(2023年版)[J]. 中国实用妇科与产科杂志, 2023, 39(10):996-1002. DOI: 10.19538/j.fk2023100109.
[3]
周晖, 刘昀昀, 罗铭, 等. 《2024 NCCN子宫颈癌临床实践指南(第1版)》更新解读[J]. 中国实用妇科与产科杂志, 2023, 39(11):1119-1121. DOI 10.19538/j.fk2023020115.
[4]
Zhang W, Chen C, Liu P, et al. Impact of pelvic MRI in routine clinical practice on staging of ⅠB1-ⅡA2 cervical cancer[J]. Cancer Manag Res, 2019, 11:3603-3609. DOI:10.2147/CMAR.S197496.
[5]
Li Z, Duan H, Guo J, et al. Discussion on the rationality of FIGO 2018 stage ⅢC for cervical cancer with oncological outcomes:a cohort study[J]. Ann Transl Med, 2022, 10(2):122. DOI:10.21037/atm-21-6374.
[6]
李艳, 袁婷婷, 周苏芹, 等. 紫癜性肾炎患儿肾小球滤过率下降风险预测及列线图的建立[J]. 中国实用儿科杂志, 2025, 40(5):407-412.DOI:10.19538/j.ek2025050612.
[7]
罗玉婷, 陈纯玲, 郭予雄, 等. 先天性心脏病术后脓毒症患儿列线图预后模型的构建与验证[J]. 中国实用儿科杂志, 2024, 39(2):119-124.DOI:10.19538/j.ek2024020609.
[8]
Wang J, Zhanghuang C, Tan X, et al. A nomogram for predicting cancer-specific survival of osteosarcoma and ewing's sarcoma in children:a seer database analysis[J]. Front Public Health, 2022, 10:837506. DOI:10.3389/fpubh.2022.837506.
[9]
He Y, Luo L, Shan R, et al. Development and validation of a nomogram for predicting postoperative early relapse and survival in hepatocellular carcinoma[J]. J Natl Compr Canc Netw, 2023, 22(1D):e237069. DOI:10.6004/jnccn.2023.7069.
[10]
Wright JD, Matsuo K, Huang Y, et al. Prognostic performance of the 2018 international federation of gynecology and obstetrics cervical cancer staging guidelines[J]. Obstet Gynecol, 2019, 134(1):49-57. DOI:10.1097/AOG.0000000000003311.
[11]
Duan H, Li H, Kang S, et al. Rationality of FIGO 2018 ⅢC restaging of cervical cancer according to local tumor size:A cohort study[J]. Acta Obstet Gynecol Scand, 2023, 102(8):1045-1052. DOI:10.1111/aogs.14612.
[12]
Wang M, Ma M, Yang L, et al. Development and validation of a nomogram for predicting pelvic lymph node metastasis and prognosis in patients with cervical cancer[J]. Front Oncol, 2022, 12:952347. DOI:10.3389/fonc.2022.952347.
[13]
李梦琦, 王璐, 郭依琳, 等. 3种炎症指标与早期子宫颈癌盆腔淋巴结转移的相关性研究[J]. 中国实用妇科与产科杂志, 2023, 39(4):466-469. DOI:10.19538/j.fk2023040117.
[14]
胡鹏, 王宏兵. 淋巴结转移对中晚期子宫颈癌患者预后影响研究[J]. 中国实用妇科与产科杂志, 2022, 38(7):748-751.DOI:10.19538/j.fk2022070117.
[15]
陈林, 程安然, 陈锐, 等. 淋巴结比率可作为早期宫颈癌生存和复发的预测因子[J]. 中山大学学报(医学科学版), 2021, 42(6):950-954. DOI: 10.13471/j.cnki.j.sun.yat-sen.univ(med.sci).2021.0619.
[16]
王倩, 张敏, 冯晓宇. 非小细胞肺癌与脉管癌栓的相关性及对手术后预后的影响[J]. 实用癌症杂志, 2023, 38(1):148-151. DOI:10.3969/j.issn.1001-5930.2023.01.043.
[17]
刘萍, 黎志强, 柳攀, 等. FIGO 2018子宫颈癌分期Ⅲ期各亚期设置合理性探讨[J]. 中国实用妇科与产科杂志, 2021, 37(6):669-672. DOI:10.19538/j.fk2021060116.
[18]
Balaya V, Guani B, Magaud L, et al. Validation of the 2018 FIGO classification for cervical cancer:lymphovascular space invasion should be considered in ⅠB1 Stage[J]. Cancers (Basel), 2020, 12(12):3554.DOI:10.3390/cancers12123554.
[19]
Chang H, Wang M, Liu Y, et al. Parametrial involvement and decreased survival of women with FIGO stage ⅢC1 cervical cancer[J]. J Gynecol Oncol, 2023, 34(4):e46. DOI:10.3802/jgo.2023.34.e46.

Funding

Natural Science Research Projects in Anhui Universities(2023byzd057)
PDF(1378 KB)

Accesses

Citation

Detail

Sections
Recommended

/